Skip to main navigation Skip to search Skip to main content

In the Emerging Era of GLP-1 Receptor Agonists There Is an Unrecognized Need to Change the Formulation of Oral Urologic Agents for Erectile Dysfunction, Benign Prostatic Hyperplasia, and Overactive Bladder

  • Ashwin Ramaswamy
  • , Steven A. Kaplan

Research output: Contribution to journalEditorial

Original languageEnglish
JournalJournal of Urology
VolumePublish Ahead of Print
DOIs
StatePublished - 26 May 2026

Cite this